Selbyville, DE -- (SBWIRE) -- 11/06/2018 -- Global Insulin Delivery Devices Market set to exceed USD 19 billion by 2024; according to a new research report by Global Market Insights.

Increasing prevalence of diabetes and adoption of insulin delivery devices are the major factors driving the global market. Rapidly growing demand for needle free minimally invasive delivery system fuels market growth and should significant augment the overall industry expansion in foreseeable future. Rising diabetes diagnosis rate worldwide, especially in developing countries is generating demand for insulin and thereby delivery devices. Furthermore, insurance coverage and reimbursement by public sector organizations for diabetes management in number of countries will favor market growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1649

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

1. Roche
2. Eli Lilly and Company
3. Medtronic
4. Novo Nordisk
5. Sanofi
6. BD
7. Wockhardt Ltd.
8. Insulet Corporation
9. Ypsomed AG

Insulin pens' business segment dominated the market in 2017, valuing over USD 6.6 billion and is forecast to hold its position by 2024. Within the insulin pen business, reusable pens will growth with CAGR more than 6.5% during the forecast period. The demand for injection free minimally invasive systems will drive pumps' market growth over the forecast timeframe. Factors such as, ease of use, needleless insulin delivery and portability will result in rapid adoption of the same in coming 5-7 years. The insulin pumps market is forecast to grow with CAGR of over 7% during projection years.

UK insulin delivery devices market valued over USD 500 million in 2017 and is forecast to grow with a commanding CAGR during the projection years. Demand for insulin pens happens to be high across the nation; however, demand for pumps, which has been lesser popular devices, should rise significantly over the forecast timeframe. India insulin devices market should witness 13.5% growth owing to high number of diabetic population being untapped and increasing incidences of the same. Improving healthcare system, growing disposable income and awareness will be some of the major factors driving market growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1649

Insulin Delivery Devices Market by Product
o Pumps
- Tubed
- Tubeless

o Pens
- Reusable
- Disposable

o Pen Needles
- Standard
- Safety